Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The DNA-directed RNA polymerase beta subunit is the second-largest subunit of the bacterial multisubunit RNA polymerase core enzyme and is encoded by the rpoB gene. Together with the β′ subunit, it forms the catalytic center essential for RNA synthesis from DNA templates. The β subunit plays a key role in binding nucleotides, catalyzing phosphodiester bond formation, and interacting with DNA and nascent RNA during transcription. This subunit is a well-established antimicrobial target, as several clinically important antibiotics (such as rifampicin) inhibit bacterial RNA polymerase by binding to the β subunit and preventing transcription, particularly in pathogens like Mycobacterium tuberculosis. Mutations in the β subunit can confer drug resistance, making it a molecular biomarker for antibiotic susceptibility testing and treatment monitoring[2][3][4][7].
Inhibition of RNA synthesis by binding the β subunit and blocking transcription elongation Allosteric inhibition of the RNA polymerase catalytic site
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA-directed RNA polymerase beta subunit, bacterial type (RNAP β subunit).